I want more information
What is ThyroidPrint?
A test that avoids unnecessary thyroid surgeries
If you have been diagnosed with an indeterminate thyroid nodule (Bethesda III or IV), your risk of cancer ranges between 15 to 30%. If your ThyroidPrint test result is benign the risk of cancer of your nodule falls to less than 5% and you can forgo a diagnostic surgery.
Play Video
SIMPLE & EFFECTIVE
ThyroidPrint in numbers
+
0
Tests performed
Available in
0
Countries
+
0
%
Surgeries avoided
+
0
Years of research
Centers working with us
ThyroidPrint, available worldwide to improve your quality of life
ThyroidPrint is a test clinically validated in the United States and Latin America, developed by GeneproDX. Our mission is to change how indeterminate thyroid nodules are diagnosed and treated worldwide.
What do
our patients say?
Play Video
Testimonial Ximena Urzua
Play Video
Testimonial Macarena Bustamante
Play Video
Testimonial María Sonia Herrera
Authorizations and accreditations
Our clinical laboratory is CAP-accredited (College of American Pathologists), which is the highest standard accreditation for clinical laboratories worldwide.
Partners
